Cardiovascular changes following DOCA-NaCl or conditioning in 6-hydroxydopamine-treated rats.
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001921:Brain; D001923:Brain Chemistry / Q000187:drug effects; D002395:Catecholamines / Q000378:metabolism; D003214:Conditioning, Classical; D003900:Desoxycorticosterone / Q000494:pharmacology*; D004562:Electrocardiography; D004597:Electroshock; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D006892:Hydroxydopamines / Q000494:pharmacology*; D007267:Injections; D007668:Kidney / Q000502:physiology; D008297:Male; D009392:Nephrectomy; D010293:Pargyline / Q000494:pharmacology; D010991:Plethysmography; D051381:Rats; D012965:Sodium Chloride / Q000494:pharmacology*; D013997:Time Factors; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
D002395:Catecholamines; D006892:Hydroxydopamines; D003900:Desoxycorticosterone; D012965:Sodium Chloride; D010293:Pargyline; D014446:Tyrosine 3-Monooxygenase